IR@PKUHSC  > 北京大学第二临床医学院
学科主题临床医学
Inhibition of T-cell activition with HLA-DR1/DR4 restricted non-T-cell stimulating peptides
Zhou, QA; Cheng, YJ; Lu, HS; Zhou, WH; Li, ZG
关键词Activation Hla-dr Altered Peptides Collagen Ii t Cell
刊名HUMAN IMMUNOLOGY
2003-09-01
DOI10.1016/S0198-8859(03)00143-5
64期:9页:857-865
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Immunology
研究领域[WOS]Immunology
关键词[WOS]COLLAGEN-INDUCED ARTHRITIS ; MYELIN BASIC-PROTEIN ; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS ; HISTOCOMPATIBILITY COMPLEX-MOLECULES ; SHARED EPITOPE HYPOTHESIS ; ANTIGEN-PRESENTING CELLS ; HLA-DR MOLECULES ; MHC CLASS-II ; RHEUMATOID-ARTHRITIS ; SYNTHETIC COPOLYMER-1
英文摘要

It has been reported that collagen II (CII) derived peptide CII263-272 induced T-cell activation via its amino acids responsible for T-cell receptor (TCR) recognition. The impact of substitution of the TCR contacting amino acids of CII263-272 on T-cell activation was evaluated in this study using a panel of altered CII263-272 peptides. Computer modeling revealed that the side chains of 263F and 266E in CII263-272 were coupled with amino acids on alpha1 and beta1 chains of HLA-DR1 or -DR4, mainly via hydrogen bonds, whereas the side chains of 267Q and 270K protrude out of the cleft and might be recognized by TCR. Intracellular delivery of the altered peptides, and their binding to HLA-DR1 and -DR4 molecules on cell surface, were demonstrated by confocal microscopy and flow cytometry. The results also revealed that the substitution of 267Q, 268G, 269P, and 270K individually or consecutively by alanine (A) or glycine (G) led to weak or non-T-cell responses. Furthermore, the altered peptides with 270K substitution (270A) or with consecutive substitution of 268G, 269P, and 270K (sub268-270) dramatically inhibited T-cell activation. It is suggested that the altered peptides derived from CII263-272 with substitution of amino acids responsible for TCR contact might be of inhibitory effect on T-cell responses. (C) American Society for Histocompatibility and Immunogenetics, 2003. Published by Elsevier Inc.

语种英语
WOS记录号WOS:000185197900004
引用统计
被引频次:8[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/55764
专题北京大学第二临床医学院
作者单位1.Peking Univ, Sch Med, Dept Rheumatol & Immunol, Peoples Hosp, Beijing 100871, Peoples R China
2.Peking Univ, Sch Med, Arthritis Res Inst, Peoples Hosp, Beijing 100871, Peoples R China
3.Tsing Hua Univ, Inst Biophys & Struct Biol, Beijing 100084, Peoples R China
推荐引用方式
GB/T 7714
Zhou, QA,Cheng, YJ,Lu, HS,et al. Inhibition of T-cell activition with HLA-DR1/DR4 restricted non-T-cell stimulating peptides[J]. HUMAN IMMUNOLOGY,2003,64(9):857-865.
APA Zhou, QA,Cheng, YJ,Lu, HS,Zhou, WH,&Li, ZG.(2003).Inhibition of T-cell activition with HLA-DR1/DR4 restricted non-T-cell stimulating peptides.HUMAN IMMUNOLOGY,64(9),857-865.
MLA Zhou, QA,et al."Inhibition of T-cell activition with HLA-DR1/DR4 restricted non-T-cell stimulating peptides".HUMAN IMMUNOLOGY 64.9(2003):857-865.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zhou, QA]的文章
[Cheng, YJ]的文章
[Lu, HS]的文章
百度学术
百度学术中相似的文章
[Zhou, QA]的文章
[Cheng, YJ]的文章
[Lu, HS]的文章
必应学术
必应学术中相似的文章
[Zhou, QA]的文章
[Cheng, YJ]的文章
[Lu, HS]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。